|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.230 AUD | -6.69% |
|
-11.86% | -18.01% |
| 02-06 | ASX Biggest Losers | MT |
| 01-29 | Mesoblast to Start Site Enrollment in Pivotal Trial for Cell Therapy Label Extension; Shares Fall 4% | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
- Stock Market
- Equities
- MSB Stock
- Charts Mesoblast Limited
- Total Return chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















